Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine

被引:12
作者
Butler, Kimberly S. [1 ]
Young, Megan Y. L. [1 ]
Li, Zhihua [2 ]
Elespuru, Rosalie K. [1 ]
Wood, Steven C. [1 ]
机构
[1] US FDA, Off Med Prod & Tobacco, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs,Div Biol Chem & Mat Sci, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Off Med Prod & Tobacco, Ctr Drug Evaluat & Res, Off Translat Sci,Off Clin Pharmacol,Div Appl Regu, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
Next generation sequencing; Cancer Hotspot panel; Ion Torrent Personal Genome Machine; Mutation detection; Systematic error analysis; Performance analysis; DIAGNOSTICS; GENES;
D O I
10.1016/j.yrtph.2015.09.011
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Next-Generation Sequencing is a rapidly advancing technology that has research and clinical applications. For many cancers, it is important to know the precise mutation(s) present, as specific mutations could indicate or contra-indicate certain treatments as well as be indicative of prognosis. Using the Ion Torrent Personal Genome Machine and the AmpliSeq Cancer Hotspot panel v2, we sequenced two pancreatic cancer cell lines, BxPC-3 and HPAF-II, alone or in mixtures, to determine the error rate, sensitivity, and reproducibility of this system. The system resulted in coverage averaging 2000x across the various amplicons and was able to reliably and reproducibly identify mutations present at a rate of 5%. Identification of mutations present at a lower rate was possible by altering the parameters by which calls were made, but with an increase in erroneous, low-level calls. The panel was able to identify known mutations in these cell lines that are present in the COSMIC database. In addition, other, novel mutations were also identified that may prove clinically useful. The system was assessed for systematic errors such as homopolymer effects, end of amplicon effects and patterns in NO CALL sequence. Overall, the system is adequate at identifying the known, targeted mutations in the panel. Published by Elsevier Inc.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 24 条
  • [1] Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms
    Bolotin, Dmitry A.
    Mamedov, Ilgar Z.
    Britanova, Olga V.
    Zvyagin, Ivan V.
    Shagin, Dmitriy
    Ustyugova, Svetlana V.
    Turchaninova, Maria A.
    Lukyanov, Sergey
    Lebedev, Yury B.
    Chudakov, Dmitriy M.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (11) : 3073 - 3083
  • [2] Shining a Light on Dark Sequencing: Characterising Errors in Ion Torrent PGM Data
    Bragg, Lauren M.
    Stone, Glenn
    Butler, Margaret K.
    Hugenholtz, Philip
    Tyson, Gene W.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (04)
  • [3] Phenotype and Genotype of Pancreatic Cancer Cell Lines
    Deer, Emily L.
    Gonzalez-Hernandez, Jessica
    Coursen, Jill D.
    Shea, Jill E.
    Ngatia, Josephat
    Scaife, Courtney L.
    Firpo, Matthew A.
    Mulvihill, Sean J.
    [J]. PANCREAS, 2010, 39 (04) : 425 - 435
  • [4] High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers
    Fassan, Matteo
    Simbolo, Michele
    Bria, Emilio
    Mafficini, Andrea
    Pilotto, Sara
    Capelli, Paola
    Bencivenga, Maria
    Pecori, Sara
    Luchini, Claudio
    Neves, Diogo
    Turri, Giona
    Vicentini, Caterina
    Montagna, Licia
    Tomezzoli, Anna
    Tortora, Giampaolo
    Chilosi, Marco
    De Manzoni, Giovanni
    Scarpa, Aldo
    [J]. GASTRIC CANCER, 2014, 17 (03) : 442 - 449
  • [5] Molecular diagnostics of a single multifocal non-small cell lung cancer case using targeted next generation sequencing
    Geurts-Giele, Willemina R. R.
    Dirkx-van der Velden, Albertina W.
    Bartalits, Natascha M. M. T.
    Verhoog, Leon C.
    Hanselaar, Wessel E. J. J.
    Dinjens, Winand N. M.
    [J]. VIRCHOWS ARCHIV, 2013, 462 (02) : 249 - 254
  • [6] Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
    Hadd, Andrew G.
    Houghton, Jeff
    Choudhary, Ashish
    Sah, Sachin
    Chen, Liangjing
    Marko, Adam C.
    Sanford, Tiffany
    Buddavarapu, Kalyan
    Krosting, Julie
    Garmire, Lana
    Wylie, Dennis
    Shinde, Rupali
    Beaudenon, Sylvie
    Alexander, Erik K.
    Mambo, Elizabeth
    Adai, Alex T.
    Latham, Gary J.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (02) : 234 - 247
  • [7] Fundamentals of Pyrosequencing
    Harrington, Colleen T.
    Lin, Elaine I.
    Olson, Matthew T.
    Eshleman, James R.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (09) : 1296 - 1303
  • [8] Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma
    Kim, Hye Sook
    Sung, Jae Sook
    Yang, Song-Ju
    Kwon, Nak-Jung
    Jin, LiHua
    Kim, Seung Tae
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Han Kyeom
    Kang, Jin-Hyoung
    Kim, Jeong-Oh
    Park, Jae Yong
    Choi, Jin Eun
    Yoon, HyoungKyu
    Park, Chan Kwon
    Yang, Kap-Seok
    Seo, Jeong-Sun
    Kim, Yeul Hong
    [J]. PLOS ONE, 2013, 8 (12):
  • [9] Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement
    Lee, Cheng-Han
    Hoang, Lien N.
    Yip, Stephen
    Reyes, Carolina
    Marino-Enriquez, Adrian
    Eilers, Grant
    Tao, Derrick
    Chiang, Sarah
    Fletcher, Jonathan A.
    Soslow, Robert A.
    Nucci, Marisa R.
    Oliva, Esther
    [J]. MODERN PATHOLOGY, 2014, 27 (05) : 751 - 757
  • [10] Performance comparison of benchtop high-throughput sequencing platforms
    Loman, Nicholas J.
    Misra, Raju V.
    Dallman, Timothy J.
    Constantinidou, Chrystala
    Gharbia, Saheer E.
    Wain, John
    Pallen, Mark J.
    [J]. NATURE BIOTECHNOLOGY, 2012, 30 (05) : 434 - +